Efficacy and safety data for the Ab interno XEN45 gel stent implant at 3 Years: A retrospective analysis.

Purpose: To report efficacy and safety measures of the XEN45 gel stent at 36 months in the UK National Health Service setting.

Methods: Retrospective non-comparative audit of the records of patients who underwent XEN45 implantation between June 2015 and May 2017 was performed. Main outcome measures were intraocular pressure and number of antihypertensive medications used.

Efficacy and safety data for the XEN45 implant at 2 years: a retrospective analysis.

Aim: To report efficacy and safety measures for XEN45 in a National Health Service setting after 24-month follow-up.

Methods: This is a retrospective, non-comparative audit of records of patients who underwent XEN45 procedure between June 2015 and May 2017. The main outcome measures were intraocular pressure (IOP) reduction and number of antihypertensive medications at each timepoint.